JAYPIRCA 50 mg/1 (Pirtobrutinib TABLET, COATED) 50 mg/1

JAYPIRCA 50 mg is a coated tablet containing pirtobrutinib, used for targeted therapy. This medication is designed for oral administration and is available in a pack of 30 tablets.

Strength

50 mg/1

Pack Size

30 TABLET, COATED in 1 BOTTLE (0002-6902-30)

Manufacturer / TM Owner

Eli Lilly and Company

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

JAYPIRCA 50 mg is primarily used for targeted therapy in certain conditions. Pirtobrutinib, the active ingredient, is often explored for its potential in managing specific health challenges. Patients and healthcare providers may consider this medication as part of a broader treatment plan.

Side Effects

Common effects of JAYPIRCA 50 mg may include mild to moderate reactions that vary among individuals. Some users might experience common side effects such as fatigue or gastrointestinal discomfort. It's important to monitor any unusual symptoms and consult a healthcare professional if concerns arise.

Precautions & Warnings

Handling JAYPIRCA 50 mg requires careful consideration of individual health profiles. Patients should follow the guidance of their healthcare provider regarding administration and monitoring. Proper storage and adherence to prescribed usage are essential for optimal results.

Avoid Interactions

JAYPIRCA 50 mg may interact with certain substances, including other medications or supplements. It's advisable to discuss all current treatments with a healthcare provider to avoid potential interactions. Alcohol and specific foods might also influence the effectiveness of pirtobrutinib.

Frequently Asked Questions

JAYPIRCA 50 mg is used for targeted therapy in certain conditions, often as part of a broader treatment plan.

JAYPIRCA 50 mg is designed for oral administration. Follow the instructions provided by your healthcare provider for proper usage.

Common side effects may include fatigue and gastrointestinal discomfort. Always consult a healthcare professional if you experience any unusual symptoms.

It's advisable to discuss alcohol consumption with your healthcare provider, as it may interact with the medication.

Store JAYPIRCA 50 mg in a cool, dry place, away from direct sunlight and out of reach of children.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.